相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The increasing value of plant-made proteins
Markus Sack et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies
Alex Xenopoulos
JOURNAL OF BIOTECHNOLOGY (2015)
The business impact of an integrated continuous biomanufacturing platform for recombinant protein production
Jason Walther et al.
JOURNAL OF BIOTECHNOLOGY (2015)
Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals
Barry R. Holtz et al.
PLANT BIOTECHNOLOGY JOURNAL (2015)
Techno-Economic Analysis of Horseradish Peroxidase Production Using a Transient Expression System in Nicotiana benthamiana
David Richard Walwyn et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2015)
The therapeutic monoclonal antibody market
Dawn M. Ecker et al.
MABS (2015)
Expression and glycoengineering of functionally active heteromultimeric IgM in plants
Andreas Loos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Manufacturing Economics of Plant-Made Biologics: Case Studies in Therapeutic and Industrial Enzymesy
Daniel Tuse et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Virus-like particles produced in plants as potential vaccines
Nunzia Scotti et al.
EXPERT REVIEW OF VACCINES (2013)
Predictive models for transient protein expression in tobacco (Nicotiana tabacum L.) can optimize process time, yield, and downstream costs
J. F. Buyel et al.
BIOTECHNOLOGY AND BIOENGINEERING (2012)
First plant-made biologic approved
Jeffrey L Fox
NATURE BIOTECHNOLOGY (2012)
Plant Proteins Involved in Agrobacterium-Mediated Genetic Transformation
Stanton B. Gelvin
ANNUAL REVIEW OF PHYTOPATHOLOGY, VOL 48 (2010)
Production of antibodies in plants: status after twenty years
Benoit De Muynck et al.
PLANT BIOTECHNOLOGY JOURNAL (2010)
Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
Nathalie Landry et al.
PLOS ONE (2010)
A novel two-component Tobacco mosaic virus-based vector system for high-level expression of multiple therapeutic proteins including a human monoclonal antibody in plants
Gourgopal Roy et al.
VIROLOGY (2010)
Plants as bioreactors: Recent developments and emerging opportunities
Arun K. Sharma et al.
BIOTECHNOLOGY ADVANCES (2009)
Industrialization of mAb production technology The bioprocessing industry at a crossroads
Brian Kelley
MABS (2009)
Process economics of industrial monoclonal antibody manufacture
Suzanne S. Farid
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Antibody production
John R. Birch et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain
S Nandi et al.
TRANSGENIC RESEARCH (2005)
Secretory IgA antibodies from plants
KL Wycoff
CURRENT PHARMACEUTICAL DESIGN (2005)
Economic aspects of commercial manufacture of biopharmaceuticals
RG Werner
JOURNAL OF BIOTECHNOLOGY (2004)
In planta engineering of viral RNA replicons:: Efficient assembly by recombination of DNA modules delivered by Agrobacterium
S Marillonnet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The production of recombinant pharmaceutical proteins in plants
JKC Ma et al.
NATURE REVIEWS GENETICS (2003)
分享论文
